Chemed (CHE) Non-Current Deferred Tax Liability (2009 - 2026)

Chemed has reported Non-Current Deferred Tax Liability for 18 years, with the latest figure at $14.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 23.82% year-over-year to $14.6 million; the trailing twelve-month figure through Mar 2026 stood at $14.6 million (up 23.82% YoY), and the FY2025 full-year result was $19.3 million, down 25.56% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $14.6 million, down from $19.3 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $38.6 million in Q4 2022, with the low at $9.7 million in Q3 2025.
• Average Non-Current Deferred Tax Liability over 5 years is $24.7 million, with a median of $25.9 million recorded in 2024.
• Year-over-year, Non-Current Deferred Tax Liability soared 85.09% in 2023 and plunged 65.5% in 2025.
• Tracing CHE's Non-Current Deferred Tax Liability over 5 years: stood at $38.6 million in 2022, then declined by 21.47% to $30.3 million in 2023, then declined by 14.43% to $25.9 million in 2024, then fell by 25.56% to $19.3 million in 2025, then decreased by 24.53% to $14.6 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $14.6 million (Q1 2026), $19.3 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.

Peer Comparison